Kent State University

Kent State University, located in Kent, Ohio, is a prominent public doctoral university established in 1910, recognized for its high research activity. As the highest-ranking public university in Northern Ohio, it offers a diverse array of academic programs, including undergraduate majors in fields such as Biomedical Sciences, Communication Studies, Psychology, and Visual Communication and Design. Students have access to over 300 academic programs across Kent State's eight campuses and can participate in more than 200 student organizations, fostering a vibrant campus life. The university provides various financial aid options, including need-based awards and graduate assistantships, to support students in their educational pursuits. Admissions for freshmen require a minimum GPA and standardized test scores, though alternative pathways exist for those who do not meet these criteria. Kent State University plays a vital role in the educational landscape of Ohio, contributing to the development of its students through comprehensive academic and extracurricular offerings.

Stephen Roberts

Director, Technology Commercialization and Research Finance

2 past transactions

RXQ Compounding

Series A in 2018
RXQ Compounding, LLC is a manufacturer and distributor of sterile and non-sterile medications based in Athens, Ohio. Founded in 2014, the company operates as an FDA approved 503B Outsourcing Facility and offers a diverse range of products, including injectable medications, veterinary treatments, dermatologic creams, ophthalmic solutions, orthopedic steroids, and custom compounding services for hospitals. RXQ Compounding emphasizes safety and quality by adhering to stringent procedural standards, ensuring that its products meet regulatory requirements. The company markets its offerings online, aiming to provide healthcare providers with reliable access to compounded drugs and minimize delivery times for optimal patient outcomes. Through its partnership with the Ohio University Innovation Center, RXQ Compounding seeks to become a leader in the evolving landscape of pharmaceutical manufacturing.

Remesh

Seed Round in 2014
Remesh Inc. is a U.S.-based company that specializes in an AI-powered platform designed for real-time audience engagement and insights. Founded in 2013, Remesh enables users to conduct live conversations with up to 1,000 participants simultaneously, allowing for the collective expression of thoughts and opinions within a group. The platform integrates artificial intelligence with market research, facilitating the rapid collection, analysis, and presentation of feedback from customers or employees. This technology empowers businesses to understand their audiences better and make informed decisions based on real-time data, enhancing their ability to gather valuable insights from their clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.